Abstract
with acute AF, while twenty-seven had chronic AF. The majority with acute AF were male (62%), of European descent (75%) with average age of 68 (16-87) years. Twenty-three (31%) patients were managed with a rate control strategy, twenty-four (33%) patients self-reverted to sinus rhythm and twenty-six (36%) patients underwent cardioversion. Patients undergoing cardioversion tended to be younger (64 vs 75 years) with lower mean CHA2DS2VASc score (2.8 vs 3.4) than patients treated with rate control. Twenty patients received direct current cardioversion (DCCV) with 95% successful restoration of sinus rhythm at discharge. Chemical cardioversion (Amiodarone 8, Flecainide 5) was successful in six out of thirteen patients (46%). There were no complications related to cardioversion. Conclusion: Cardioversion still plays a role in the management of acute AF but tends to be reserved for selected younger, lower risk patients. Rates of successful in-hospital restoration of sinus rhythm were higher with DCCV compared to chemical cardioversion.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
